Ticker > Company >

Acutaas Chemicals share price

Acutaas Chemicals Ltd.

  3.11 L   457   91 NSE: ACUTAAS BSE: 543349 SECTOR: Pharmaceuticals & Drugs

3164.45
-35.00 (-1.09%)
BSE: 04 Sep 04:01 PM

Price Summary

Today's High

₹ 3226

Today's Low

₹ 3160

52 Week High

₹ 3735

52 Week Low

₹ 1290.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

25907.71 Cr.

Enterprise Value

25766.76 Cr.

No. of Shares

8.19 Cr.

P/E

65.19

P/B

14.88

Face Value

₹ 5

Div. Yield

0.08 %

Book Value (TTM)

₹  212.67

CASH

165 Cr.

DEBT

24.05 Cr.

Promoter Holding

32.66 %

EPS (TTM)

₹  48.54

Sales Growth

33.74%

ROE

24.6 %

ROCE

32.94%

Profit Growth

129.51 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 24Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year33.74%
3 Year28.99%
5 Year31.19%

Profit Growth

1 Year129.51%
3 Year63.78%
5 Year46.64%

ROE%

1 Year24.6%
3 Year15.87%
5 Year16.76%

ROCE %

1 Year32.94%
3 Year21.05%
5 Year21.54%

Debt/Equity

0.0144

Price to Cash Flow

84.84

Interest Cover Ratio

161.1371

CFO/PAT (5 Yr. Avg.)

0.784026894646902

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 32.66 0.00
Mar 2026 32.66 0.00
Dec 2025 32.66 0.00
Sep 2025 32.66 0.00
Jun 2025 32.66 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 63.7847682127367% for the Past 3 years.
  • The company has shown a good revenue growth of 28.9949978900255% for the Past 3 years.
  • Company has been maintaining healthy ROCE of 21.0493% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 161.1371.
  • The Company has been maintaining an effective average operating margins of 23.00002% in the last 5 years.
  • Company’s PEG ratio is 0.503377512899231.
  • The company has an efficient Cash Conversion Cycle of 45.2402 days.
  • Company has a healthy liquidity position with current ratio of 3.6184.

 Limitations

  • The company is trading at a high PE of 65.19.
  • The company is trading at a high EV/EBITDA of 44.7319.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 205.97 305.19 390.86 421.77 322.41
Total Expenditure 154.98 208.59 236.66 240.56 212.73
Operating Profit 50.99 96.61 154.19 181.22 109.68
Other Income 16.02 8.97 6.34 14.55 4.48
Interest 0.62 0.57 0.81 1.07 1.12
Depreciation 7.46 7.72 9.02 8.83 9.02
Exceptional Items 0 0 0 0 0
Profit Before Tax 58.93 97.28 150.7 185.86 104.02
Tax 14.28 24.39 39.14 48.79 28.12
Profit After Tax 44.65 72.89 111.56 137.07 75.9
Adjusted EPS (Rs) 5.45 8.9 13.63 16.74 9.27

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 520.14 616.73 687.58 989.83 1323.79
Total Expenditure 414.96 494.07 579.92 764.69 840.79
Operating Profit 105.18 122.66 107.67 225.14 483.01
Other Income 2.76 4.32 13.79 18.34 45.88
Interest 6.41 2.41 5.89 5.86 3.08
Depreciation 10.08 12.34 14.69 24.05 33.03
Exceptional Items 0 0 -31.75 0 0
Profit Before Tax 91.45 112.22 69.11 213.58 492.77
Tax 19.5 28.88 25.42 54.03 126.6
Net Profit 71.95 83.34 43.68 159.55 366.17
Adjusted EPS (Rs.) 9.87 11.44 5.92 9.74 44.73

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 36.44 36.44 36.88 40.93 40.94
Total Reserves 481.57 550.35 638.23 1270.66 1627.45
Borrowings 0.59 0.38 113.64 0 0
Other N/C liabilities 6.7 9.51 14.65 27.32 43.5
Current liabilities 129.31 162.78 267.84 199.04 223.57
Total Liabilities 654.61 759.46 1071.25 1537.95 1935.45
Assets
Net Block 177.88 222.09 357.06 499.23 600.84
Capital WIP 1.89 25.52 125.42 130.28 228.43
Intangible WIP 1.07 4.28 0 0 0
Investments 33.4 33.45 67.73 67.73 117.66
Loans & Advances 7.78 17.19 51.67 58.86 176.56
Other N/C Assets 5.87 2.21 1.56 8.47 3
Current Assets 426.71 454.71 467.81 773.38 808.96
Total Assets 654.61 759.46 1071.25 1537.95 1935.45
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 91.45 112.22 69.11 213.58 492.77
Adjustment 12.36 11.19 41.84 14.6 9.16
Changes in Assets & Liabilities -90.68 -43.23 6.02 -68.54 -86.23
Tax Paid -22.81 -24.45 -16.12 -43.72 -110.33
Operating Cash Flow -9.69 55.73 100.85 115.93 305.37
Investing Cash Flow -122.47 -20.47 -337.32 -234.37 -333.61
Financing Cash Flow 140.26 -14.44 235.48 273.56 3.68
Net Cash Flow 8.1 20.82 -0.99 155.12 -24.57

Corporate Actions

Investors Details

PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
promoters 32.66 32.66 32.66 32.66 32.66
nareshkumar ramjibhai pat... 17.69 17.69 17.69 17.69 17.69
vaghasia chetankumar chha... 14.97 14.97 14.97 14.97 14.97
PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
investors 67.34 67.34 67.34 67.34 67.34
axis max life insurance l... 2.59 2.59 2.53 2.14 2.19
dhwani girishkumar chovat... 3.35 3.35 3.35 3.35 3.35
government pension fund g... 3.54 3.54 3.54 3.54 3.54
kotak mahindra trustee co... 3.78 3.78 3.84 3.95 3.53
llp 0.19 0.23 0.45 0.28 0.24
sbi healthcare opportunit... - - - 1.92 2.35
vanaja sundar iyer 1.16 1.16 1.16 1.16 1.14
union small cap fund 1.02 1.39 1.31 1.37 -
bank of india small cap f... 1.59 1.71 1.35 - -
sbi large & midcap fund 4.06 3.54 2.68 - -
aditya birla sun life ins... 1.63 1.45 - - -
ashoka whiteoak icav - as... 1.17 1.09 - - -
government of singapore 1.33 1.12 - - -
uti small cap fund 1.15 1.25 - - -
ashish kacholia 1.17 - - - -
tata mutual fund - tata e... 1.14 - - - -
vanguard total internatio... 1.09 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2024

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
Research IDBI Capital
Research IDBI Capital
Research IDBI Capital
Research IDBI Capital
Research IDBI Capital
Research IDBI Capital
Research IDBI Capital
Research HDFC Securities
Research Report By:
Research IDBI Capital
Research IDBI Capital
Research IDBI Capital
Research BP Wealth
Research BOB Capital Market

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY22
Concall Q3FY25
Concall Q3FY24
Concall Q3FY22
Concall Q2FY24
Concall Q1FY24
Concall Q1FY24
Concall Q1FY23
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY26
Presentation Q4FY24
Presentation Q4FY22
Presentation Q3FY24
Presentation Q3FY22
Presentation Q2FY22
Presentation Q1FY27

Company News

Acutaas Chemicals inaugurates pilot plant in Surat 4 Sep, 2:29 PM Acutaas Chemicals informs about press release 28 Aug, 1:07 PM Acutaas Chemicals’ arm inaugurates semiconductor chemicals manufacturing plant in South Korea 28 Aug, 11:51 AM Acutaas Chemicals gets nod for Rs 212 crore capital expenditure plan 24 Aug, 12:30 PM Acutaas Chemicals informs about updates 18 Aug, 5:33 PM Acutaas Chemicals - Quaterly Results 25 Jul, 12:00 AM Acutaas Chemicals informs about conference call 20 Jul, 5:13 PM Acutaas Chemicals submits board meeting intimation 20 Jul, 1:28 PM Acutaas Chemicals informs about disclosures 23 Jun, 11:59 AM Acutaas Chemicals informs about corporate presentation 16 May, 3:43 PM Acutaas Chemicals - Quaterly Results 1 May, 12:00 AM Acutaas Chemicals board to consider dividend 27 Apr, 3:02 PM Acutaas Chemicals informs about board meeting 27 Apr, 12:22 PM Acutaas Chemicals informs about board meeting 27 Apr, 12:19 PM Acutaas Chemicals informs about analyst meet 2 Mar, 3:28 PM Acutaas Chemicals’ arm buys 75% stake in JV company in South Korea 12 Feb, 2:42 PM Acutaas Chemicals informs about press release 29 Jan, 12:28 PM Acutaas Chemicals - Quaterly Results 29 Jan, 12:00 AM Acutaas Chemicals informs about updates 19 Jan, 3:42 PM Acutaas Chemicals informs about analyst meet 11 Nov, 2:33 PM Acutaas Chemicals informs about transcript of earnings conference call 24 Oct, 12:55 PM Acutaas Chemicals - Quaterly Results 18 Oct, 12:00 AM Acutaas Chemicals informs about outcome of board meeting 17 Oct, 2:44 PM Acutaas Chemicals - Quaterly Results 30 Jul, 1:39 PM Acutaas Chemicals - Quaterly Results 30 Jul, 1:39 PM Acutaas Chemicals - Quaterly Results 30 Jul, 1:39 PM Acutaas Chemicals informs about certificate 11 Jul, 6:09 PM Acutaas Chemicals informs about analyst meet 4 Jun, 5:20 PM Kotak Mahindra Mutual Fund buys 6.6% stake in Acutaas Chemicals 20 May, 10:30 AM Ami Organics informs about press release 2 May, 5:59 PM Ami Organics informs about audited financial results 2 May, 3:18 PM AMI Organics - Quaterly Results 2 May, 1:10 PM AMI Organics - Quaterly Results 2 May, 1:10 PM AMI Organics - Quaterly Results 2 May, 1:10 PM Ami Organics commissions 10.8 MW DC solar power plant in Gujarat 3 Apr, 5:43 PM AMI Organics informs about press release 3 Apr, 4:41 PM Ami Organics submits analyst meet intimation 22 Feb, 12:19 PM Ami Organics informs about earnings call transcript 1 Feb, 4:05 PM AMI Organics informs about newspaper publication 30 Jan, 5:25 PM Ami Organics informs about statement of deviation or variation 29 Jan, 2:55 PM AMI Organics - Quaterly Results 28 Jan, 5:57 PM AMI Organics - Quaterly Results 28 Jan, 5:57 PM AMI Organics - Quaterly Results 28 Jan, 5:57 PM AMI Organics informs about closure of trading window 26 Dec, 12:42 PM Ami Organics informs about credit rating 18 Dec, 12:06 PM Ami Organics informs about disclosure 13 Dec, 5:15 PM Ami Organics gets nod to enhance capital expenditure for brownfield project 12 Dec, 10:30 AM AMI Organics informs about conference meet 12 Nov, 5:02 PM Ami Organics informs about statement of deviation or variation 29 Oct, 4:48 PM AMI Organics - Quaterly Results 29 Oct, 12:10 PM

Acutaas Chemicals Stock Price Analysis and Quick Research Report. Is Acutaas Chemicals an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Acutaas Chemicals. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Acutaas Chemicals has a PE ratio of 65.7384060120637 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Acutaas Chemicals has ROA of 21.0844% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Acutaas Chemicals has a Current ratio of 3.6184.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Acutaas Chemicals has a ROE of 24.6022%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Acutaas Chemicals has a Debt to Equity ratio of 0.0144 which means that the company has low proportion of debt in its capital.

  • Sales growth: Acutaas Chemicals has reported revenue growth of 33.7387% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Acutaas Chemicals for the current financial year is 36.4864666826108%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Acutaas Chemicals is Rs 2.5 and the yield is 0.0784%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Acutaas Chemicals is Rs 48.5424. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Acutaas Chemicals in Ticker for free. Also, one can get the intrinsic value of Acutaas Chemicals by using Valuation Calculators, which are available with a Finology ONE subscription. 

Acutaas Chemicals FAQs

Q1. What is Acutaas Chemicals share price today?
Ans: The current share price of Acutaas Chemicals is Rs 3191.1.

Q2. What is the market capitalisation of Acutaas Chemicals?
Ans: Acutaas Chemicals has a market capitalisation of Rs 26125.89374142 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Acutaas Chemicals?
Ans: The PE ratio of Acutaas Chemicals is 65.7384060120637 and the P/B ratio of Acutaas Chemicals is 15.0047890625992, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Acutaas Chemicals share?
Ans: The 52-week high share price of Acutaas Chemicals is Rs 3740, and the 52-week low share price of Acutaas Chemicals is Rs 1302.

Q5. Does Acutaas Chemicals pay dividends?
Ans: Currently, Acutaas Chemicals pays dividends. Dividend yield of Acutaas Chemicals is around 0.0784%.

Q6. What are the face value and book value of Acutaas Chemicals shares?
Ans: The face value of Acutaas Chemicals shares is Rs 5, while the book value per share of Acutaas Chemicals is around Rs 212.6721. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Acutaas Chemicals?
Ans: Acutaas Chemicals has a total debt of Rs 24.0504 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Acutaas Chemicals?
Ans: The ROE of Acutaas Chemicals is 24.6022% and ROCE of Acutaas Chemicals is 32.9427%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Acutaas Chemicals a good buy for the long term?
Ans: The Acutaas Chemicals long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Acutaas Chemicals undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Acutaas Chemicals appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Acutaas Chemicals’s financials?
Ans: You can review Acutaas Chemicals’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Acutaas Chemicals
X